Page last updated: 2024-10-29
ketamine and Envenomation, Snakebite
ketamine has been researched along with Envenomation, Snakebite in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Research Excerpts
Excerpt | Relevance | Reference |
" Ketamine is on the WHO's list of essential medications and is used for a variety of pharmacologic applications including anesthesia and acute pain management." | 7.96 | Ketamine for pain control of snake envenomation in Guinea: A case series. ( Balde, C; Benjamin, JM; Brandehoff, N; Chippaux, JP, 2020) |
" Ketamine is on the WHO's list of essential medications and is used for a variety of pharmacologic applications including anesthesia and acute pain management." | 3.96 | Ketamine for pain control of snake envenomation in Guinea: A case series. ( Balde, C; Benjamin, JM; Brandehoff, N; Chippaux, JP, 2020) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors
Authors | Studies |
Brandehoff, N | 1 |
Benjamin, JM | 1 |
Balde, C | 1 |
Chippaux, JP | 1 |
Clinical Trials (1)
Trial Overview
Trial | Phase | Enrollment | Study Type | Start Date | Status |
Pilot Study: Ketamine for Acute Pain After Rattlesnake Envenomation[NCT05379179] | Phase 4 | 40 participants (Anticipated) | Interventional | 2022-06-20 | Enrolling by invitation |
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Other Studies
1 other study available for ketamine and Envenomation, Snakebite